Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB-AOOE Cause Visual impairment? 229 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Visual impairment have been filed in association with ERENUMAB-AOOE. This represents 0.5% of all adverse event reports for ERENUMAB-AOOE.

229
Reports of Visual impairment with ERENUMAB-AOOE
0.5%
of all ERENUMAB-AOOE reports
22
Deaths
42
Hospitalizations

How Dangerous Is Visual impairment From ERENUMAB-AOOE?

Of the 229 reports, 22 (9.6%) resulted in death, 42 (18.3%) required hospitalization, and 27 (11.8%) were considered life-threatening.

Is Visual impairment Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 229 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB-AOOE Cause?

Accidental exposure to product (9,923) Device difficult to use (9,530) Wrong technique in product usage process (9,359) Drug dose omission by device (6,340) Migraine (4,290) Drug ineffective (3,813) Constipation (3,104) Product storage error (2,958) Headache (2,787) Injection site pain (2,715)

What Other Drugs Cause Visual impairment?

INSULIN GLARGINE (5,793) INSULIN LISPRO (4,654) ADALIMUMAB (3,770) DUPILUMAB (3,089) ETANERCEPT (2,489) FINGOLIMOD (2,147) AFLIBERCEPT (1,836) PREGABALIN (1,714) METHOTREXATE (1,588) TOFACITINIB (1,544)

Which ERENUMAB-AOOE Alternatives Have Lower Visual impairment Risk?

ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE ERENUMAB-AOOE vs ERGOCALCIFEROL ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB-AOOE vs ERIBULIN ERENUMAB-AOOE vs ERLOTINIB

Related Pages

ERENUMAB-AOOE Full Profile All Visual impairment Reports All Drugs Causing Visual impairment ERENUMAB-AOOE Demographics